Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen

对于高危、首次复发的B细胞急性淋巴细胞白血病患儿，无论采用何种预处理方案，与化疗相比，Blinatumomab均能带来更好的移植后疗效。